Search research articles
Contact Us
Filters
Showing results (421-430 of 456) with videos related to
Page
of 46
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 15, 2018
Elective Nodal Irradiation Attenuates the Combinatorial Efficacy of Stereotactic Radiation Therapy and Immunotherapy
Ariel E Marciscano, Ali Ghasemzadeh, Thomas R Nirschl, et al.
Nature Cancer
|
February 5, 2022
Castration-mediated IL-8 promotes myeloid infiltration and prostate cancer progression
Zoila A Lopez-Bujanda, Michael C Haffner, Matthew G Chaimowitz, et al.
Physical Review Letters
|
December 31, 2008
Experimental constraints on a dark matter origin for the DAMA annual modulation effect
C E Aalseth, P S Barbeau, D G Cerdeño, et al.
European Urology
|
August 20, 2020
Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors
Karim Fizazi, Charles G Drake, Tomasz M Beer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 9, 2017
Muscadine Grape Skin Extract (MPX) in Men with Biochemically Recurrent Prostate Cancer: A Randomized, Multicenter, Placebo-Controlled Clinical Trial
Channing J Paller, Xian C Zhou, Elisabeth I Heath, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 30, 2021
Lack of consensus identifies important areas for future clinical research: Advanced Prostate Cancer Consensus Conference (APCCC) 2019 findings
Ursula M Vogl, Tomasz M Beer, Ian D Davis, et al.
Science (New York, N.Y.)
|
January 6, 2018
Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma
Diana Miao, Claire A Margolis, Wenhua Gao, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 24, 2024
Fc-enhanced anti-CTLA-4 depletes tumor-infiltrating regulatory T cells to augment immune effects of androgen ablation in high-risk prostate cancer
Casey R Ager, Aleksandar Obradovic, Patrick McCann, et al.
Cancer Discovery
|
January 28, 2021
An Empirical Antigen Selection Method Identifies Neoantigens That Either Elicit Broad Antitumor T-cell Responses or Drive Tumor Growth
Hubert Lam, Lisa K McNeil, Hanna Starobinets, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 1, 2016
Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas
Jennifer E Kim, Mira A Patel, Antonella Mangraviti, et al.
Page
of 46
Search research articles
Search
Showing results (421-430 of 456) with videos related to
Sort By:
Page
of 46
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 15, 2018
Elective Nodal Irradiation Attenuates the Combinatorial Efficacy of Stereotactic Radiation Therapy and Immunotherapy
Ariel E Marciscano, Ali Ghasemzadeh, Thomas R Nirschl, et al.
Nature Cancer
|
February 5, 2022
Castration-mediated IL-8 promotes myeloid infiltration and prostate cancer progression
Zoila A Lopez-Bujanda, Michael C Haffner, Matthew G Chaimowitz, et al.
Physical Review Letters
|
December 31, 2008
Experimental constraints on a dark matter origin for the DAMA annual modulation effect
C E Aalseth, P S Barbeau, D G Cerdeño, et al.
European Urology
|
August 20, 2020
Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors
Karim Fizazi, Charles G Drake, Tomasz M Beer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 9, 2017
Muscadine Grape Skin Extract (MPX) in Men with Biochemically Recurrent Prostate Cancer: A Randomized, Multicenter, Placebo-Controlled Clinical Trial
Channing J Paller, Xian C Zhou, Elisabeth I Heath, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 30, 2021
Lack of consensus identifies important areas for future clinical research: Advanced Prostate Cancer Consensus Conference (APCCC) 2019 findings
Ursula M Vogl, Tomasz M Beer, Ian D Davis, et al.
Science (New York, N.Y.)
|
January 6, 2018
Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma
Diana Miao, Claire A Margolis, Wenhua Gao, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 24, 2024
Fc-enhanced anti-CTLA-4 depletes tumor-infiltrating regulatory T cells to augment immune effects of androgen ablation in high-risk prostate cancer
Casey R Ager, Aleksandar Obradovic, Patrick McCann, et al.
Cancer Discovery
|
January 28, 2021
An Empirical Antigen Selection Method Identifies Neoantigens That Either Elicit Broad Antitumor T-cell Responses or Drive Tumor Growth
Hubert Lam, Lisa K McNeil, Hanna Starobinets, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 1, 2016
Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas
Jennifer E Kim, Mira A Patel, Antonella Mangraviti, et al.
Page
of 46